Welcome to the BR1DGE Learning Hub
Advancing Knowledge in Type 1 Diabetes
The BR1DGE Learning Hubs offer comprehensive, evidence-based modules designed to empower healthcare professionals with the knowledge and tools needed to transform early detection and management of type 1 diabetes (T1D).
These Learning Hubs guide you through five interconnected modules that build upon each other to deliver a complete clinical picture of T1D: from understanding T1D disease burden to implementing screening programs and exploring both current and emerging monitoring and management strategies.
The Burden of Early Stage Type 1 Diabetes and Diagnosis at Clinical Onset
Learn more about the burden of T1D, with a focus on how the condition affects children, families, and caregivers. You’ll cover the psychosocial impact of presymptomatic and diagnosed T1D, the value of early detection and screening, and the importance of communication, education, and support in helping people cope with risk and diagnosis.
Early Detection of Autoimmune Type 1 Diabetes
Learn how to identify T1D before symptoms appear, and why early detection can improve outcomes. Learn more about key markers like islet autoantibodies, explore screening strategies, target populations, communication approaches, and the importance of follow-up care after screening.
Exploring the Pathophysiology and Stages of Autoimmune Type 1 Diabetes
Learn how T1D develops, including the immune attack on beta cells, and what genetic and environmental factors can be involved. Learn about the stages of the disease and how progression can be identified and understood before clinical onset.
Monitoring the Progression of Autoimmune Type 1 Diabetes
Learn how to monitor people at risk, or in the early stages of T1D. Explore the benefits of psychosocial support, the role of C-peptide in diagnosis and prognosis, and why ongoing monitoring is important.
The Current and Emerging Management of Autoimmune Type 1 Diabetes
Learn about current evidence-based approaches to managing T1D, including insulin therapy and its limitations. Uncover emerging immunotherapies and how future treatment may focus on preserving beta-cell function.
MAT-GLB-2602596 - 1.0 - 05/2026